Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study [Clinical Sciences]
Conclusions—
Among recent lacunar stroke patients, IL-6 and TNF receptor concentrations predict risk of recurrent vascular events, and they are associated with the effect of antiplatelet therapies.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306.
Source: Stroke - Category: Neurology Authors: Boehme, A. K., McClure, L. A., Zhang, Y., Luna, J. M., Del Brutto, O. H., Benavente, O. R., Elkind, M. S. V. Tags: Ischemic Stroke Clinical Sciences Source Type: research
More News: Cholesterol | Clinical Trials | Heart Attack | Ischemic Stroke | Neurology | Statin Therapy | Stroke | Study